Status:
UNKNOWN
An Exploratory Study of Increased Preterm Arginine INTake (PAINT18)
Lead Sponsor:
Liverpool Women's NHS Foundation Trust
Collaborating Sponsors:
University of Liverpool
University of California, Davis
Conditions:
Preterm
Nutritional Deficiency
Eligibility:
All Genders
22-29 years
Phase:
NA
Brief Summary
PAINT18 is a nutrition study focusing on the effect of arginine supplementation on immune function in preterm infants. The investigators will explore the effect of current intravenous feeding (parent...
Detailed Description
Title The effect of increased Preterm Arginine INTake on biological pathways affecting immune function in infants requiring early parenteral nutrition (PAINT-18 ) Population Preterm infants \<29 week...
Eligibility Criteria
Inclusion
- Infants born \<29 weeks' gestation
- and/or with birthweight \<1200g
- Admitted to the Neonatal Unit at Liverpool Women's Hospital within 48 hours of birth.
Exclusion
- Infants who are unlikely to survive the first week after birth.
- Infants known (or suspected to have) a diagnosis of inborn error of metabolism or serious liver dysfunction
- Parents who are unable to give informed consent
Key Trial Info
Start Date :
December 7 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT05299112
Start Date
December 7 2021
End Date
June 30 2025
Last Update
September 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Liverpool Women's Hospital
Liverpool, Merseyside, United Kingdom, L8 7SS